Emerging therapies in Multiple Myeloma: Leveraging immune checkpoint inhibitors for improved outcomes
{{output}}
Background:: Multiple Myeloma is a hematological malignancy characterized by the proliferation of clonal plasma cells and associated with severe clinical manifestations. Despite advancements in diagnosis and management, Multiple ... ...
